Zusammenfassung
Hintergrund
Wir berichten über die Entwicklung einer multifunktionellen, silikonbeschichteten Polyesterprothese.
Material und Methoden
Herkömmliche Polyesterprothesen wurden mit Silikon beschichtet. Es folgte eine Oberflächenmodifizierung mit unterschiedlichen Molekülen. Anschließend wurden Substanzen in die Matrix des Silikons eingebracht, die wieder abgegeben werden können. Die Prothesen wurden hinsichtlich ihrer physikalischen und biologischen Eigenschaften analysiert.
Ergebnisse
In ihren physikalischen Charakteristika, wie z. B. Dichtigkeit, Compliance und Steifigkeit, ist eine mit 16–20 mg/cm2 Silikon-beschichtete Prothese mit herkömmlichen Materialien vergleichbar. Bei der Thrombogenität zeigten die Polyvinylalkohol- und phosphocholinmodifizierten Prothesen Vorteile. Die eluierten Substanzen wurden je nach Eigenschaften entweder bevorzugt ins Medium (ASS) oder in angrenzendes Gewebe abgegeben (Sudanrot, Sirolimus, weiteres Immunsuppressivum). Im Tierversuch konnte durch die Abgabe der Substanzen ein Effekt auf die Intimahyperplasie demonstriert werden.
Schlussfolgerung
Die hier vorgestellte Prothese ist hinsichtlich ihrer Eigenschaften beliebig modifizierbar. Neben der Verbesserung der Hämokompatibilität steht mit der Elution von Molekülen ein geeignetes Instrument zur lokalen Medikamentenfreisetzung zur Verfügung.
Abstract
Background
Herein we report on the development of a multifunctional, silicone-coated polyester graft.
Methods
Normal polyester prostheses were coated with silicone. Afterwards, the surface was modified with different functional groups. In addition, substances with the aim of elution were incorporated into the bulk of the silicone. We analyzed these grafts regarding their physical and biological properties.
Results
Physical and biological characteristics (such as density, compliance, and stiffness) of a polyester graft coated with 16–20 mg silicone/cm2 are comparable to a normal prosthesis. In surface modification, polyvinylalcohol and phosphocholine-modified materials showed advantages regarding thrombogenicity. The eluted molecules could be found preferentially in the medium used (ASS) or in the tissue adjacent to the bypass (Sudan red, sirolimus, and another immunosuppressive drug). In the animal study, the elution of the substances was demonstrated by the effect on the intimal hyperplasia.
Conclusions
The prosthesis presented in this paper may be modified in many ways. Besides optimizing the hemocompatibility, the elution of molecules offers a tremendous tool for local drug release.
Literatur
Ao PY, Hawthorne WJ, Vicaretti M Fletcher JP (2000) Development of intimal hyperplasia in six different vascular prostheses. Eur J Vasc Endovasc Surg 20: 241–249
Asahara T, Bauters C, Pastore C et al. (1995) Local delivery of vascular endothelial growth factor accelerates reendothelialization and attenuates intimal hyperplasia in balloon-injured rat carotid artery. Circulation 91: 2793–2801
Bartorelli AL, Trabattoni D, Fabbiocchi F et al. (2003) Synergy of passive coating and targeted drug delivery: the tacrolimus-eluting Janus Carbo Stent. J Interv Cardiol 16: 499–505
Boffa GA, Lucien N, Faure A, Boffa MC (1977) Polytetrafluoroethylene-N-vinylpyrrolidone graft copolymers: affinity with plasma proteins. J Biomed Mater Res 11: 317–337
Brinton LA, Lubin JH, Burich MC et al. (2000) Breast cancer following augmentation mammoplasty (United States). Cancer Causes Control 11: 819–827
Chen C, Lumsden AB, Ofenloch JC et al. (1997) Phosphorylcholine coating of ePTFE grafts reduces neointimal hyperplasia in canine model. Ann Vasc Surg 11: 74–79
Cholakis CH, Sefton MV (1989) In vitro platelet interactions with a heparin-polyvinyl alcohol hydrogel. J Biomed Mater Res 23: 399–415
Debus ES, Larena-Avellaneda A, Dietz UA, Siegel R, Gattenlöhner S, Franke S (2002) Die silikonbeschichtete Polyesterprothese—Ergebnisse nach subrenalem Aortenersatz im Hundemodell. Gefäßchirurgie 7: 65–69
Dormandy JA, Rutherford RB (2000) Management of peripheral arterial disease (PAD). TASC Working Group. TransAtlantic Inter-Society Concensus (TASC). J Vasc Surg 31: S1–S296
Drasler WJ, Wilson GJ, Stenoien MD et al. (1993) A spun elastomeric graft for dialysis access. ASAIO J 39: 114–119
Drury JK, Ashton TR, Cunningham JD, Maini R, Pollock JG (1987) Experimental and clinical experience with a gelatin impregnated Dacron prosthesis. Ann Vasc Surg 1: 542–547
Duda SH, Pusich B, Richter G et al. (2002) Sirolimus-eluting stents for the treatment of obstructive superficial femoral artery disease: six-month results. Circulation 106: 1505–1509
Farb A, Heller PF, Shroff S et al. (2001) Pathological analysis of local delivery of paclitaxel via a polymer-coated stent. Circulation 104: 473–479
Farrar DJ (2000) Development of a prosthetic coronary artery bypass graft. Heart Surg Forum 3: 36–40
Fontaine AB, Borsa JJ, Dos Passos S et al. (2001) Evaluation of local abciximab delivery from the surface of a polymer-coated covered stent: in vivo canine studies. J Vasc Interv Radiol 12: 487–492
Godo MN, Sefton MV (1999) Characterization of transient platelet contacts on a polyvinyl alcohol hydrogel by video microscopy. Biomaterials 20: 1117–1126
Gombotz WR, Wang GH, Horbett TA, Hoffman AS (1991) Protein adsorption to poly(ethylene oxide) surfaces. J Biomed Mater Res 25: 1547–1562
Granke K, Ochsner JL, McClugage SG, Zdrahal P (1993) Analysis of graft healing in a new elastomer-coated vascular prosthesis. Cardiovasc Surg 1: 254–261
Harris JM, Martin LF (1987) An in vitro study of the properties influencing Staphylococcus epidermidis adhesion to prosthetic vascular graft materials. Ann Surg 206: 612–620
Hwang CW, Wu D, Edelman ER (2001) Physiological transport forces govern drug distribution for stent-based delivery. Circulation 104: 600–605
Ji J, Feng L, Barbosa MA (2001) Stearyl poly(ethylene oxide) grafted surfaces for preferential adsorption of albumin. Biomaterials 22: 3015–3023
Keough EM, Mackey WC, Connolly R et al. (1985) The interaction of blood components with PDMS (polydimethylsiloxane) and LDPE (low-density polyethylene) in a baboon ex vivo arteriovenous shunt model. J Biomed Mater Res 19: 577–587
Lee JH, Jeong BJ, Lee HB (1997) Plasma protein adsorption and platelet adhesion onto comb-like PEO gradient surfaces. J Biomed Mater Res 34: 105–114
Lumsden AB, Chen C, Coyle KA, Ofenloch JC, Wang JH, Yasuda HK, Hanson SR (1996) Nonporous silicone polymer coating of expanded polytetrafluoroethylene grafts reduces graft neointimal hyperplasia in dog and baboon models. J Vasc Surg 24: 825–833
Nakayama Y, Nishi S, Ishibashi-Ueda H (2003) Fabrication of drug-eluting covered stents with micropores and differential coating of heparin and FK506. Cardiovasc Radiat Med 4: 77–82
Okoshi T (1995) New concept of microporous structure in small diameter vascular prostheses. Artif Organs 19: 27–31
Seare WJ Jr, Pantalos GM, Burns GL, Burt WR, Olsen DB (1993) Quantitative bacterial analysis of porous, fabric, and smooth non-blood contacting implant surfaces and their tissue interfaces in a 169 day pneumatic total artificial heart animal recipient. ASAIO J 39: M668–74
Silber S (2003) Paclitaxel-eluting stents: are they all equal? An analysis of six randomized controlled trials in de novo lesions of 3,319 patients. J Interv Cardiol 16: 485–490
Stratton JR, Thiele BL, Ritchie JL (1983) Natural history of platelet deposition on Dacron aortic bifurcation grafts in the first year after implantation. Am J Cardiol 52: 371–374
Van Belle E, Maillard L, Tio FO, Isner JM (1997) Accelerated endothelialization by local delivery of recombinant human vascular endothelial growth factor reduces in-stent intimal formation. Biochem Biophys Res Commun 235: 311–316
Walpoth BH, Pavlicek M, Celik B et al. (2001) Prevention of neointimal proliferation by immunosuppression in synthetic vascular grafts. Eur J Cardiothorac Surg 19: 487–492
Wan WK, Lovich MA, Hwang CW, Edelman ER (1999) Measurement of drug distribution in vascular tissue using quantitative fluorescence microscopy. J Pharm Sci 88: 822–829
Wendel HP, Philipp A, Weber N, Birnbaum DE, Ziemer G (2001) Oxygenator thrombosis: worst case after development of an abnormal pressure gradient--incidence and pathway. Perfusion 16: 271–278
Whalen RL, Cardona RR, Kantrowitz A (1992) A new, all silicone rubber small vessel prosthesis. ASAIO J 38: M207–212
White RA, Klein SR, Shors EC (1987) Preservation of compliance in a small diameter microporous, silicone rubber vascular prosthesis. J Cardiovasc Surg (Torino) 28: 485–490
Interessenkonflikt:
Der korrespondierende Autor versichert, dass keine Verbindungen mit einer Firma, deren Produkt in dem Artikel genannt ist, oder einer Firma, die ein Konkurrenzprodukt vertreibt, bestehen.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Larena-Avellaneda, A., Debus, E.S., Siegel, R. et al. Die Silikon-beschichtete Polyester-Prothese. Gefässchirurgie 9, 105–110 (2004). https://doi.org/10.1007/s00772-004-0340-9
Issue Date:
DOI: https://doi.org/10.1007/s00772-004-0340-9